KPTI logo

Karyopharm Therapeutics (KPTI) Return On Equity

Annual ROE

41.08%
-63.98%-60.90%

December 31, 2024

Summary

Performance

1-Year Change

-60.9%

3-Year Change

-73.62%

5-Year Change

+123.97%

15-Year Change

+146.45%

KPTI ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

86.2%
KPTI annual return on equity is higher than 86.2% of companies in Healthcare sector

High & Low

All-time High

992.38%
KPTI annual return on equity is currently -95.86% below its historical high of 992.38%

3-Year Low

41.08%
KPTI annual return on equity is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
KPTI previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
KPTI next annual earnings announcement has not yet been scheduled

OtherKPTIprofitabilitymetrics:

Annual Revenue

$145.24 M
KPTI annual revenue is $145.24 million

Annual Net Income

-$76.42 M
KPTI annual net profit is -$76.42 million

Annual EPS

-$0.93
KPTI annual earnings per share is -$0.93

Annual ROA

-37.75%
KPTI annual return on assets is -37.75%

Quarterly ROE

47.26%
-11.36%-19.38%

December 31, 2024

Summary

Performance

3-Month Change

-19.38%

1-Year Change

-19.38%

3-Year Change

-68.73%

5-Year Change

+123.52%

KPTI Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

88.12%
KPTI quarterly return on equity is higher than 88.12% of companies in Healthcare sector

High & Low

All-time High

496.77%
KPTI quarterly return on equity is currently -90.49% below its historical high of 496.77%

3-Year Low

47.26%
KPTI quarterly return on equity is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
KPTI previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
KPTI next earnings announcement has not yet been scheduled

OtherKPTIprofitabilitymetrics:

Quarterly Revenue

$30.54 M
KPTI quarterly revenue is $30.54 million

Quarterly Net Income

-$30.78 M
KPTI quarterly net profit is -$30.78 million

Quarterly EPS

-$0.24
KPTI quarterly earnings per share is -$0.24

Quarterly ROA

-39.58%
KPTI quarterly return on assets is -39.58%

ROE Formula

ROE =  Net Income
Shareholders Equity ✕ 100%

Annual ROE

41.08%
KPTI annual return on equity is 41.08%

Annual Net Income

-$76.42 M
KPTI annual net profit is -$76.42 million

Annual Shareholders Equity

-$186.02 M
KPTI annual stockholders equity is -$186.02 million

KPTI ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-60.9%-19.4%
3 y3 years-73.6%-68.7%
5 y5 years+124.0%+123.5%

KPTI ROE Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-95.9%at low-80.3%at low
5 y5-year-95.9%+110.5%-88.6%+106.4%
alltimeall time-95.9%+110.5%-90.5%+106.4%

Karyopharm Therapeutics ROE History

DateAnnualQuarterly
Dec 2024
41.08%(-60.9%)
47.26%(-19.4%)
Sep 2024
-
58.62%(-12.4%)
Jun 2024
-
66.89%(-45.5%)
Mar 2024
-
122.76%(-24.3%)
Dec 2023
105.06%(-89.4%)
162.14%(-32.3%)
Sep 2023
-
239.46%(+15.6%)
Jun 2023
-
207.18%(+4.4%)
Mar 2023
-
198.49%(+7.0%)
Dec 2022
992.38%(+537.2%)
185.54%(+120.9%)
Sep 2022
-
84.00%(-17.9%)
Jun 2022
-
102.26%(-12.0%)
Mar 2022
-
116.25%(-23.1%)
Dec 2021
155.75%(-139.8%)
151.13%(-63.7%)
Sep 2021
-
416.20%(-156.6%)
Jun 2021
-
-735.49%(+186.2%)
Mar 2021
-
-256.97%(+25.7%)
Dec 2020
-391.29%(+128.3%)
-204.44%(-0.7%)
Sep 2020
-
-205.88%(+6.1%)
Jun 2020
-
-194.00%(-0.2%)
Mar 2020
-
-194.31%(-3.3%)
Dec 2019
-171.36%(+50.1%)
-200.97%(+18.7%)
Sep 2019
-
-169.25%(+21.0%)
Jun 2019
-
-139.91%(+6.5%)
Mar 2019
-
-131.36%(+16.7%)
Dec 2018
-114.13%
-112.53%(+6.1%)
DateAnnualQuarterly
Sep 2018
-
-106.06%(+11.7%)
Jun 2018
-
-94.99%(-7.3%)
Mar 2018
-
-102.44%(+17.2%)
Dec 2017
-88.43%(+45.5%)
-87.39%(+16.0%)
Sep 2017
-
-75.36%(+6.3%)
Jun 2017
-
-70.87%(+0.6%)
Mar 2017
-
-70.44%(+10.3%)
Dec 2016
-60.77%(+4.2%)
-63.85%(+4.8%)
Sep 2016
-
-60.93%(+4.2%)
Jun 2016
-
-58.50%(+9.8%)
Mar 2016
-
-53.26%(+3.5%)
Dec 2015
-58.34%(+39.2%)
-51.45%(+5.3%)
Sep 2015
-
-48.84%(+1.9%)
Jun 2015
-
-47.93%(+7.2%)
Mar 2015
-
-44.71%(+2.1%)
Dec 2014
-41.90%(-21.6%)
-43.79%(-13.7%)
Sep 2014
-
-50.75%(-12.9%)
Jun 2014
-
-58.25%(-21.5%)
Mar 2014
-
-74.18%(-23.9%)
Dec 2013
-53.44%(-193.8%)
-97.54%(-119.6%)
Sep 2013
-
496.77%(-491.2%)
Jun 2013
-
-126.97%(-362.5%)
Mar 2013
-
48.37%(+71.3%)
Dec 2012
56.99%(-30.1%)
28.24%
Dec 2011
81.50%
-

FAQ

  • What is Karyopharm Therapeutics annual return on equity?
  • What is the all time high annual ROE for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics annual ROE year-on-year change?
  • What is Karyopharm Therapeutics quarterly return on equity?
  • What is the all time high quarterly ROE for Karyopharm Therapeutics?
  • What is Karyopharm Therapeutics quarterly ROE year-on-year change?

What is Karyopharm Therapeutics annual return on equity?

The current annual ROE of KPTI is 41.08%

What is the all time high annual ROE for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high annual return on equity is 992.38%

What is Karyopharm Therapeutics annual ROE year-on-year change?

Over the past year, KPTI annual return on equity has changed by -63.98% (-60.90%)

What is Karyopharm Therapeutics quarterly return on equity?

The current quarterly ROE of KPTI is 47.26%

What is the all time high quarterly ROE for Karyopharm Therapeutics?

Karyopharm Therapeutics all-time high quarterly return on equity is 496.77%

What is Karyopharm Therapeutics quarterly ROE year-on-year change?

Over the past year, KPTI quarterly return on equity has changed by -11.36% (-19.38%)